Advertisement

Topics

Europe Nucleic Acid Testing/NAT Market 2021: France, Germany, Italy, Spain, UKSupplier Shares and Strategies, Country Volume and Sales Segment ForecastsInfectious and Genetic Diseases, Cancer, Forensic and Paternity Testing [Report Updated: 27062017] Pric

05:30 EDT 1 Jul 2017 | BioPortfolio Report Blog

Complete report $19,700.nbsp; DataPack test volumes, sales forecasts, supplier shares $12,800.

This new 1,273page comprehensive fivecountry report from VPGMarketResearch is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries France, Germany, Italy, Spain, UK; provides 5year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and costeffective automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.nbsp;nbsp;

Table of Contents

I.nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Introduction

II.nbsp;nbsp;nbsp;nbsp;nbsp; Worldwide Technology and Market Overview

nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; A.nbsp; DNA Sequencing
nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;
nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; B.nbsp; DNA and RNA Probes Technology
nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;
nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; C.nbsp; Detection Technologies
nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;
nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; D.nbsp; Instrumentation Review
nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;
nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; E.nbsp; Biochips: Genosensors, Microarrays, and LabsontheChip

nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; F.nbsp; Pharmacogenomics

nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; G.nbsp; Major Applications

III.nbsp;nbsp;nbsp;nbsp; France

IV.nbsp;nbsp;nbsp;nbsp; Germany

V.nbsp;nbsp;nbsp;nbsp;nbsp; Italy

VI.nbsp;nbsp;nbsp;nbsp; Spain

VII.nbsp;nbsp;nbsp; U.K.

VIII.nbsp;nbsp; Major Product Development Opportunities

IX.nbsp;nbsp;nbsp;nbsp; Design Criteria for Decentralized Testing Products

X.nbsp;nbsp;nbsp;nbsp; nbsp;Alternative Market Penetration Strategies

XI.nbsp; nbsp;nbsp;nbsp;Potential Market Entry Barriers and Risks

XII.nbsp; nbsp;nbsp;Competitive Assessments

XIII.nbsp;nbsp; Appendix
nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;
Contains 1,273 pages and 139 tables

Original Article: Europe Nucleic Acid Testing/NAT Market 2021: France, Germany, Italy, Spain, UKSupplier Shares and Strategies, Country Volume and Sales Segment ForecastsInfectious and Genetic Diseases, Cancer, Forensic and Paternity Testing [Report Updated: 27062017] Pric

NEXT ARTICLE

More From BioPortfolio on "Europe Nucleic Acid Testing/NAT Market 2021: France, Germany, Italy, Spain, UKSupplier Shares and Strategies, Country Volume and Sales Segment ForecastsInfectious and Genetic Diseases, Cancer, Forensic and Paternity Testing [Report Updated: 27062017] Pric"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...